Dallas, Texas From private practice.
Plast Reconstr Surg. 2011 Jul;128(1):17-25. doi: 10.1097/PRS.0b013e3182134aa3.
This article is an update to the decision and management algorithms for management of periprosthetic space infection or seroma following breast augmentation, originally published in "Decision and Management Algorithms to Address Patient and Food and Drug Administration Concerns Regarding Breast Augmentation and Implants," published in the October 2004 issue of this Journal. This update specifically addresses additional diagnosis and management alternatives for management of seroma in breast augmentation patients that may relate to lymphoproliferative disorders or anaplastic large cell lymphoma.
本文是对“乳房增大术后假体周围间隙感染或血清肿的决策和管理算法”的更新,该文最初发表于本刊 2004 年 10 月刊的“解决乳房增大和植入物相关患者和食品药品监督管理局关注问题的决策和管理算法”一文。本次更新特别针对与淋巴增生性疾病或间变大细胞淋巴瘤相关的乳房增大患者血清肿处理的其他额外诊断和管理选择。